FUJIFILM Diosynth Biotechnologies
Thousand Oaks, CA
Research Triangle Park, NC
College Station, TX
Holly Springs, NC
About FUJIFILM Diosynth Biotechnologies
FUJIFILM Diosynth Biotechnologies is an industry leading cGMP Contract Development and Manufacturing Organization (CDMO) supporting our partners in the biopharmaceutical industry with the development and production of their biologic, vaccines and gene therapies.
With over 30 years of experience in process development and cGMP manufacturing, a dedicated staff of over 2,000 and a reputation for excellent customer service, flexibility and responsiveness, we’ve become a trusted partner to some of the most prominent biotech developers and pharmaceutical companies in the industry.
Our Process Development experience includes the development of processes for molecules expressed via fermentation (e.g., E. coli, P. pastoris), cell culture systems including CHO, HEK, Vero, MDCK, EB66 and insect cells, and from transgenic sources.
Our network expands within five development and manufacturing facilities located in Teesside, United Kingdom; Research Triangle Park, North Carolina, USA; College Station, Texas, Thousand Oaks CA USA and Hillerød, Denmark.
Join Us - We are Hiring!
61 articles with FUJIFILM Diosynth Biotechnologies
Fujifilm Diosynth Biotechnologies Opens Dedicated State-Of-The-Art Cell Culture Process Development Laboratories In Wilton Centre
Fujifilm Diosynth Biotechnologies Announces New Service Offering To Support Development And cGMP Monoclonal Antibody Production
Fujifilm Diosynth Biotechnologies Release: Company Selects SciQuest To Automate Procurement Processes
AdAlta Pty Ltd. Signs Agreement With Fujifilm Diosynth Biotechnologies To Begin Manufacturing Its Lead Fibrosis Drug Candidate
Fujifilm Diosynth Biotechnologies Announces Collaboration On A New 20,000-Liter Microbial Biologics Facility For Use By Its Contract Development And Manufacturing Customers
Fujifilm Diosynth Biotechnologies Opens New Laboratory Facility In Research Triangle Park, NC
10 Biotech Firms Rapidly Expanding in North Carolina
Fujifilm Diosynth Biotechnologies Announces The Launch Of Its ‘Apollo™’ Mammalian Expression Platform
Fujifilm Diosynth Biotechnologies Chooses ambr250 System For Optimising Microbial Fermentation
Synthetic Biologics, Inc. And Fujifilm Diosynth Biotechnologies Announce Significant Improvement In API Manufacturing Of SYN-004 For The Prevention Of C. Difficile
Fujifilm Diosynth Biotechnologies Expands Cell Culture Manufacturing Capacity With Addition Of Two New 2,000L Single-Use Bioreactors
Fujifilm Diosynth Biotechnologies Continues Expansion Of R&D Facilities Including Addition Of Latest High Throughput Equipment
Fujifilm Diosynth Biotechnologies' UK Site Receives Renewed Medicines and Healthcare Products Regulatory Agency Manufacturing Licence
Fujifilm Diosynth Biotechnologies' Opens New Manufacturing Facility
Fujifilm Diosynth Biotechnologies Commissions New Cell Banking Facility at Billingham, UK Site
Fujifilm Diosynth Biotechnologies Manufactures a New Licensed Biopharmaceutical
Fujifilm Diosynth Biotechnologies Announces Strategic Alliance With Piramal Healthcare Limited for Production of Antibody Drug Conjugates
Fujifilm Diosynth Biotechnologies Significantly Expands Mammalian Cell Culture cGMP Capabilities
Fujifilm Diosynth Biotechnologies Expands R&D Capabilities at its Billingham, UK Site
Fujifilm Diosynth Biotechnologies and ContraFect Corporation Announce Development and Manufacturing Collaboration for Novel Anti-Staph Biologic